Tyler Jensen, SVP, Engineering and Technology Development at GenMark Diagnostics, Inc. (GNMK), sold 2,128 shares at $21.68 ($11K) on 2021-02-18, disclosed to the SEC on 2021-02-22.
Scheduled sale ($11k) by SVP, Engineering and Technology Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,628 | $0 | 0.0% |
| 2 | $21.68 | 500 | $11K | 100.0% |
| Total | $5.09 avg | 2,128 | $11K | 100% |
| Filing → |
| GNMK | SELL | 2021-02-16 | $220K | — | Filing → |
| GNMK | SELL | 2021-02-08 | $7K | — | Filing → |
| GNMK | SELL | 2021-01-29 | $5K | — | Filing → |